Avalo Therapeutics (AVTX) Q4 2024 Earnings

7NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-141
-94.04
-47.07
-0.11

Details

Expected EPS
-1.19
Actual EPS
-2.83
Surprise EPS
-1.64
Surprise Percent
+137.82%

Description

Avalo Therapeutics (AVTX) has reported earnings of -2.83 per share for Q4 2024.

0 Comments

Share your thoughts